the Efficacy and Safety of Sugammadex in Children 0-2 Years Old

NCT03728543 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Anesthesia
Pediatric Cancer
Pediatric Tumor
Pediatric Hepatoblastoma
Beta-Thalassemia
Hepatic Metastases

Interventions

DRUG: Sugammadex

Sponsor

Federal Research Institute of Pediatric Hematology, Oncology and Immunology